ArticleCold Spring Harbor molecular case studies2023
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma.
Diogo Garcia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.